Skip to main content
MedPathMedPath Home
Clinical Trials/NCT01000766
NCT01000766
Completed
Not Applicable

Identification of New Biomarkers of Drug Induced Liver Injury

University of North Carolina, Chapel Hill1 site in 1 country25 target enrollmentSeptember 2009
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsDrug Induced Liver Injury

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Drug Induced Liver Injury
Sponsor
University of North Carolina, Chapel Hill
Enrollment
25
Locations
1
Status
Completed
Last Updated
9 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSitesSimilar Trials

Overview

Brief Summary

The purpose of this study is to try to develop new blood tests that may help doctors identify if a drug is hurting a person's liver.

Detailed Description

Our hypothesis is that there are liver-specific particles, called mRNA, that are identifiable in a person's blood sample during liver injury caused by some drugs. The purpose of this study is to try to develop new blood tests that may help doctors identify if a drug is hurting a person's liver, perhaps early in the process before significant injury or illness have occurred.

Registry
clinicaltrials.gov
Start Date
September 2009
End Date
December 2013
Last Updated
9 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • •ALT \> 200 IU/L at presentation to UNC Hospitals
  • •Drug induced liver injury considered likely by admitting medical staff

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Study Sites (1)

Loading locations...

Similar Trials

Active, not recruiting
Not Applicable
Novel Serum Biomarkers for Identifying Plaque Erosion in ACS and Predicting PrognosisPlaque RuptureAcute Coronary Syndromes
NCT06763835Xuebo Liu301
Recruiting
Not Applicable
Discovery of proteins that differentiate health and disease around dental implantsPeri-ImplantitisE06.780.346.593
RBR-99xvpphniversidade Estadual de Maringá
Not yet recruiting
Not Applicable
Research to develop diagnostic and therapeutic methods for cancer of the renal pelvis and ureterCancer of the renal pelvis and ureterrenal pelvis cancer, ureteral cancerD014516, D007682
JPRN-jRCT1030220502Hayakawa Nozomi250
Completed
Not Applicable
Evaluation of Novel Biomarkers From Acutely Ill Patients at Risk for Acute Kidney InjuryAcute Kidney Injury
NCT01209169Astute Medical, Inc.890
Recruiting
Not Applicable
Identification of a New Blood Biomarker for the Diagnosis and Prognosis of LiposarcomasLiposarcomaAtypical Lipomatous Tumor
NCT04224064Institut du Cancer de Montpellier - Val d'Aurelle158